A randomised placebo-controlled multicentre trial of intravenous semapimod HCl for moderate to severe Crohn's disease.
Dotan I; Rachmilewitz D; Schreiber S; Eliakim R; van der Woude CJ; Kornbluth A; Buchman AL; Bar-Meir S; Bokemeyer B; Goldin E; Maaser C; Mahadevan U; Seidler U; Hoffman JC; Homoky D; Plasse T; Powers B; Rutgeerts P; Hommes D; Gut, 2010, vol. 59, issue 6, p 760, ISSN 14683288. ISBN 14683288.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef